Leanne Hughes Chart.PR’s Post

Meet Rutvi. Rutvi is a graduate of Biomedical Research, living in Leith. Her studies had a focus on cancer and radiation. Rutvi is in £92,000 of debt due to her studies. She's yearning for "stability" - the word permeated our time with her. So much so that she's actively considering turning her back on her studies and entering the Aldi graduate scheme. There's nothing at all wrong with the Aldi graduate scheme - but shouldn't the brightest minds in the country that have studied cancer and radiation, be trying to cure cancer? The Higher Education system was a big part of our findings in the "What the fuck is going on? with the Heartland" project with Saatchi & Saatchi UK and Richard Huntington and team. Read their excellent report here: https://lnkd.in/eHqFSuX8 And follow our newsletter for more findings over the coming weeks: https://lnkd.in/ekTUE4_Z

We are proud to announce a new partnership between City of Hope and Charles R. Drew University of Medicine and Science, the only Historically Black Graduate Institution west of the Mississippi River and one of only four Historically Black Medical Schools. Together, we will work together to create a more diverse workforce in specialized medicine through internships, curriculum, training, mentorships, joint research projects and more. "We know that more diverse representation is needed in cancer care and research,” said John Carpten, Ph.D., chief scientific officer, Irell & Manella Cancer Center Director's Distinguished Chair and Morgan & Helen Chu Director's Chair of the Beckman Research Institute at City of Hope. “We also know that there is important work to be done to close health equity gaps for people of color in the areas of early detection, clinical trials enrollment, treatment outcomes and more. That’s why we are honored to join together with Charles R. Drew University. Through this partnership, we hope to fuel a robust pipeline of diverse talent for the future, while engaging and building trust with underserved, historically excluded communities.” City of Hope plans to use the CDU partnership as a model for other exchange and training programs with Historically Black Colleges and Universities and Minority Serving Institutions in communities across our national network of cancer centers. Learn more: https://bit.ly/45oaD5T

Congratulations Marija Dinevska! awarded the ECR paper of the year - by Matrix Biology Society of Australia and New Zealand (MBSANZ) The study used Opal Polaris 7 Color multiplex-IHC from Akoya Biosciences, Inc. for cell spatial analysis. Key discoveries: 1/ immune cells, including cytotoxic T-cells, are sequestered in ECM-rich regions in brain tumors, most prominently in ECM-rich perivascular regions. 2/ Metastatic Brain Tumor ECM differs, compared with ECM in #glioblastoma #GBM. With this in mind, we are investigating ways to enhance anti-tumor immunity by mobilizing the 'ECM-trapped' immune cells. Samuel Widodo University of Melbourne The Peter Doherty Institute for Infection and Immunity #ecm #oncoimmunity #braincancer #spatialbiology

 🌐Exciting times at CNIC   📹 Our latest video dives deep into groundbreaking research to fight against the #1 killer: Cardiovascular Disease (CDV) 🔬 ❤️ 👨🔬     💡 To meet this challenge, the CNIC has defined three key goals:   - To deepen and extend our understanding of cardiovascular health   - To optimize disease prevention   - To develop advanced and innovative treatments for the most prevalent cardiovascular disorders.   ➡ Achieving these goals requires advanced research that provides detailed information on the molecular and cellular processes that underlie the disease. But it is also essential that these advances can be translated into improved health promotion, diagnosis, and treatment.   ✊ To meet these challenges, the CNIC has had to adapt.   We have moved on from a structure based on three research areas to one built around seven research programs. These programs embrace approaches from basic research to advanced clinical trials that deliver real health benefits and are built upon proven experience and rooted in advanced technological expertise in cell and animal models, imaging modalities, and massive data processing and analysis.     Watch now:   https://lnkd.in/dkGb4zeP

Registration is now open

🎉✨ *Exciting Partnership Announcement!* ✨🎉 I am thrilled to announce a significant new partnership between MTS Research Solutions (MTS SICKLE CELL FOUNDATION INC ) and Randomize Now Research Centers, a crucial step forward in our shared mission to support the Sickle Cell Disease (SCD) community through impactful research and engagement. Representation of Sickle Cell Warriors in clinical research is essential. Historically, they have been underrepresented, leading to gaps in understanding and tailored treatment options. By partnering with Randomize Now Research Centers, we aim to bridge this gap and ensure they have a voice in research. This partnership will: - Enhance Research Participation: Encourage Sickle Cell Warriors' involvement in clinical trials for treatments tailored to their needs. - Improve Patient Outcomes: Discover more effective treatments and enhance the quality of life for those with Sickle Cell Disease. - Raise Awareness: Increase awareness about the importance of clinical research participation. Ways to support us: 1. Share Study Pipelines for Sickle Cell Disease research. 2. Support Community Engagement efforts. 3. Promote Our Partnership to spread awareness. Huge thanks Danielle S. Mitchell for making this connection Black Women In Clinical Research ® Together, we can make a profound impact on the lives of Sickle Cell Warriors and their families. Your continued support is crucial for the success of this initiative. Stay tuned for more updates as our collaboration progresses! #SickleCell #ResearchPartnership #ClinicalTrials #PatientOutcomes #CommunityEngagement #RaiseAwareness

#Kudos Zhizhi Fiske, this is one of many posters you have delivered this year. A testament to your ability to combine science and learning design to deliver the impact needed to make a positive difference to health outcomes.

The future

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Bill Morice, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to honor Black History Month. They also discuss how misinformation impacts preventive health measures. https://bit.ly/49XsIc5

excellent recently published data on anti IL11 receptor antibody in this area is very interesting